Severe atopic dermatitis in a 21‐month‐old boy successfully treated with dupilumab

Daniel Mazzoni,Yolanka Lobo,David Levitt,Laura Wheller

Pediatric Dermatology（2022）

引用 0|浏览1

暂无评分

摘要

While dupilumab has emerged as a novel targeted systemic treatment for severe AD, efficacy and safety-based data in young children are limited. We discuss the case of a 21-month-old child with severe recalcitrant atopic dermatitis successfully treated with dupilumab.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要